The Cancer News Daily
The latest in cancer medicine and translational research by Wafik El-Deiry MDPhD
Related Articles
Opinion | When accepting or rejecting new drugs, the FDA will be transparent
‘Drug decision letters’ are being made public — which is good for manufacturers and patients.
After Northwestern scientist questioned for China ties died by suicide, family sues and speaks out
Jane Wu was never charged with any wrongdoing, and her family is still outraged that her lab was shut down “without explanation,” they say.
Rebranding in the Trump era: Hopkins’ campaign to save research through persuasion
After the Trump administration launched a broadside attack against the way the federal government has funded major research universities across the country, Hopkins has been…
‘Tremendous uncertainty’ for cancer research as US officials target mRNA vaccines
Amid Trump cuts and state-level backlash, experts worry that progress in messenger RNA vaccines could stall
Biomarker Testing in Advanced Cancer Still Lags Behind Guideline Recommendations
Only 35% of patients had any type of biomarker testing to guide use of targeted agents
Sylvester Innovates Fund Will Accelerate Early-Stage Cancer Discoveries and Inventions – InventUM
The $1 million Sylvester Comprehensive Cancer Center initiative aims to drive translational oncology breakthroughs.
$160 million facility to manufacture cancer treatment opens in Indianapolis
Bristol Myers Squibb is preparing to ship a new and possibly life-changing cancer treatment to patients across the world. The doses will be made and…
World’s premier cancer institute faces crippling cuts and chaos
The National Cancer Institute faces an exodus of clinicians and other staffers — some fired, others leaving in exasperation.
Kennedy’s move to cancel preventive health panel meeting raises alarm
Task force members fear the health secretary may be gearing up to fire the panel members and install new ones, as he did with a…